Body Scrub Market Size, Share & Trends Analysis Report By Type (Plant-based, Milk-based), By Distribution Channel (Hypermarket/Supermarket, Convenience Stores), By Region, And Segment Forecasts, 2025 - 2030

Body Scrub Market Size, Share & Trends Analysis Report By Type (Plant-based, Milk-based), By Distribution Channel (Hypermarket/Supermarket, Convenience Stores), By Region, And Segment Forecasts, 2025 - 2030


Body Scrub Market Growth & Trends

The global body scrub market size is expected to reach USD 24.35 billion by 2030, registering a CAGR of 5.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing awareness regarding skincare and the desire to have younger looking and healthier skin are expected to drive the market. Body scrubs, or exfoliants, have several benefits; they eliminate dead skin cells and dirt, cleanse and rejuvenate the skin, and increase blood circulation. These advantages have upped their usage and demand among consumers.

Another factor driving product uptake is increasing number of working women in developing countries such as China, India, and Brazil. A surge in disposable income has resulted in growing spending on bath and beauty products, including body scrubs. This factor is anticipated to fuel the market over the forecast period. Use of essential oils in scrubs, such as coconut oil or olive oil, helps in maintaining skin moisture and protects the skin from different allergies. This feature also drives product demand.

Asia Pacific body scrub market dominated with the largest revenue share of 34.7% in 2024. This revenue growth is attributed to high awareness regarding skincare among consumers and rapidly increasing population in countries like China and India. These countries have been attracting more players to invest in R&D so as to meet growing demands and requirements of people with various skin types.

North America body scrub market is expected to grow at the fastest CAGR of 5.6% over the forecast period. This region is expected to witness steady growth in light of higher spending power and rising awareness about healthier and younger-looking skin, especially in U.S. Furthermore, strong brand goodwill and foothold of major industry players, including Soapworks Santa Cruz and Home & Body Co., through their well-established distributor networks in the region is projected to remain a favorable trend.

Plant based dominated the market with the largest revenue share of 48.7% in 2024 owing to the many benefits they provide, resulting in a significant shift in consumer preference. An increasing number of salons and skin treatment centers globally have upped their usage and demand for these product variants to treat different skin problems.

The milk-based segment is also expected to witness rapid growth owing to increasing popularity of these product variants. They offer various benefits such as skin whitening and lightening, anti-aging, and treating sunburns. These products also have anti-inflammatory properties.

Body Scrub Market Report Highlights
  • Plant based dominated the market with the largest revenue share of 48.7% in 2024, fueled by growing uptake of these products across salons and skin treatment centers
  • The online channel is expected to grow at the fastest CAGR over the forecast period owing to a thriving e-commerce industry and easy availability of a wide range of products
  • Europe body scrub market was identified as a lucrative region in 2024. Consumers in countries likeFrance, Germany, U.K., and Spain prefer using body scrubs instead of regular soaps to exfoliate and rejuvenate the skin
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test type outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. Test location outlook
2.3. Competitive Insights
Chapter 3. Gastrointestinal Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High prevalence of substance abuse
3.2.1.2. Increase in prevalence of Gastrointestinal disorders
3.2.1.3. Technological advancements pertaining to GI diagnostics
3.2.2. Market restraint analysis
3.2.2.1. Presence of stringent rules and regulations for GI diagnostic procedures
3.3. Gastrointestinal Diagnostics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Gastrointestinal Diagnostics Market: Test Type Estimates & Trend Analysis
4.1. Test Type Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Gastrointestinal Diagnostics Market by Test Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Endoscopy
4.4.1.1. Endoscopy market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Blood Test
4.4.2.1. Blood Test market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. H. Pylori Test
4.4.3.1. H. Pylori Test market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Calprotectin Test
4.4.4.1. Calprotectin Test market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Immunoglobulin A Test
4.4.5.1. Immunoglobulin A Test market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Others
4.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Gastrointestinal Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Technology Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Gastrointestinal Diagnostics Market by Technology Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. PCR
5.4.1.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Microbiology
5.4.2.1. Microbiology market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. ELISA
5.4.3.1. ELISA market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Others
5.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Gastrointestinal Diagnostics Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Gastrointestinal Diagnostics Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Infection
6.4.1.1. Infection market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Inflammatory Bowel Disease
6.4.2.1. Inflammatory Bowel Disease market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Gastroesophageal Reflux Disease
6.4.3.1. Gastroesophageal reflux disease market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Cancer
6.4.4.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
6.4.5. Others
6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Gastrointestinal Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Test Location Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Global Gastrointestinal Diagnostics Market by Test Location Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Central Laboratories
7.4.1.1. Central Laboratories market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. Point-of-Care
7.4.2.1. Point-of-Care market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Gastrointestinal Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework/ reimbursement structure
8.6.7.3. Competitive scenario
8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework/ reimbursement structure
8.6.8.3. Competitive scenario
8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework/ reimbursement structure
8.7.5.3. Competitive scenario
8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework/ reimbursement structure
8.7.6.3. Competitive scenario
8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Regulatory framework/ reimbursement structure
8.9.1.3. Competitive scenario
8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework/ reimbursement structure
8.9.2.3. Competitive scenario
8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework/ reimbursement structure
8.9.3.3. Competitive scenario
8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework/ reimbursement structure
8.9.4.3. Competitive scenario
8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. Key company market share analysis, 2024
9.3.2. BIOMERIEUX
9.3.2.1. Company overview
9.3.2.2. Financial performance
9.3.2.3. Product benchmarking
9.3.2.4. Strategic initiatives
9.3.3. F. Hoffmann-La Roche Ltd.
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Product benchmarking
9.3.3.4. Strategic initiatives
9.3.4. Abbott
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Beckman Coulter, Inc.
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Siemens Healthineers AG
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. DiaSorin S.p.A
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. QIAGEN
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Meridian Bioscience
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Hologic, Inc.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings